Digipath
Home > Boards > US OTC > Medical - Drugs >

Innovation Pharmaceuticals Inc. (IPIX)

IPIX RSS Feed
Add IPIX Price Alert      Hide Sticky   Hide Intro
Moderator: LilKahuna, BooDog, KarinCA, sox040713, TheHound, scottsmith
Search This Board: 
Last Post: 1/24/2019 5:56:59 AM - Followers: 760 - Board type: Free - Posts Today: 2

Innovation Pharmaceuticals Inc. (IPIX)

SEC Filings  https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany

 

http://www.ipharminc.com/

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@ipharminc.com

 
About Innovation Pharmaceuticals Inc.: 

Headquartered in Beverly, Massachusetts, Innovation Pharmaceuticals is a publicly-traded company under the symbol "IPIX".
Innovation Pharmaceuticals is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Innovation Pharmaceuticals believes it has a world-class portfolio of first-in-class lead drug candidates and is now advancing them toward market approval, while actively seeking strategic partnerships. Innovation Pharmaceuticals' anti-cancer drug Kevetrin successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers' Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Innovation Pharmaceuticals has commenced a Phase 2 study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the "Guardian Angel Gene" due to its crucial role in controlling cell mutations. Innovation Pharmaceuticals is in a Phase 2 clinical trial with its novel compound Brilacidin-OM (a defensin mimetic compound) for the prevention of oral mucositis in patients with head and neck cancer. Interim analysis has shown Brilacidin-OM to have a high potential for prevention of severe oral mucositis. Clinical results are consistent with those seen in an animal model in which the occurrence of severe ulcerative oral mucositis was reduced by more than 94% compared to placebo. Innovation Pharmaceuticals' lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria ("superbugs"). In an ongoing Phase 2 open label Proof-of-Concept trial, favorable interim results have been observed in the first two cohorts of patients treated with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two types of Inflammatory Bowel Disease (IBD).  Innovation Pharmaceuticals has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available at http://www.ipharminc.com.

Management:  http://www.ipharminc.com/senior-management/

Scientific Advisors:  http://www.ipharminc.com/scientific-advisors/

Clinical Trials:  https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%2C+Inc.%22++&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Trials under previous name:   https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps

 
Product Pipeline:  http://www.ipharminc.com/therapeutic-areas/

PIPELINE: 
CLICK TO VIEW LARGER IMAGE

 

FDA DESIGNATIONS:

 

Stages of development:

stages-v2.jpg


Recent News and Press Releases: 
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/

 
SEC Filings (CIK:0001355250): 
https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com

 
Share Structure:  See SEC filing link above for current share structure

 

Innovation Pharmaceuticals IP



Patent Filings:


EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet

http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations: 

http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1


Chart:   https://stockcharts.com/h-sc/ui?s=IPIX

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

Digipath
IPIX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IPIX News: Amended Statement of Ownership (sc 13g/a) 01/22/2019 12:08:16 PM
IPIX News: Current Report Filing (8-k) 01/07/2019 04:32:21 PM
IPIX News: Current Report Filing (8-k) 12/18/2018 05:02:33 PM
IPIX News: Current Report Filing (8-k) 12/17/2018 07:07:54 AM
IPIX News: Current Report Filing (8-k) 12/17/2018 07:02:14 AM
PlusOneCoin Top Posts
#254673   There are plenty of decisions that have been Lemoncat 01/23/19 03:44:16 PM
#253950   "Leo never mentions a word about Absssi the loanranger 01/12/19 03:55:09 PM
#253635   Published Studies Confirm Cisplatin Remains Preferred Chemotherapy Component DrBones 01/08/19 08:04:14 AM
PostSubject
#253731  Sticky Note “The Misleading” – Daily Short Volume sox040713 01/08/19 08:51:48 PM
#253439  Sticky Note Prurisol Results Released -- See Link Below scottsmith 01/04/19 04:41:27 PM
#253379  Sticky Note $IPIX is motivated and working to utilize every BooDog 01/04/19 07:04:30 AM
#253363  Sticky Note Sometimes it helps to looks at some of Lemoncat 01/03/19 09:06:01 PM
#252774  Sticky Note JMO after review: farrell90 12/27/18 05:04:41 PM
#249866  Sticky Note BOARD WARNING: Please read - IH Admin [Shelly] 11/26/18 10:31:07 AM
#235000  Sticky Note IPIX Milestones, Clinical Trials, Recent Articles, Corporate Overview, Patent sox040713 07/21/18 11:52:18 PM
#254705   The patent section caught my attention also. Snowy_Owl 01/24/19 05:56:59 AM
#254703   Page 5 is interesting but mostly for the NickAidenNY 01/23/19 10:17:29 PM
#254702   There is nothing to mention. By mid-2016 we Lemoncat 01/23/19 09:42:04 PM
#254701   Not only is absssi frozen, our fearless leader Rdunn88 01/23/19 09:35:29 PM
#254700   YES AGREED AND TIME WILL COMR IPIX blanka 01/23/19 09:23:09 PM
#254699   Simply untrue. Lemoncat 01/23/19 08:55:23 PM
#254698   Still take that 400k though. MrW 01/23/19 08:39:49 PM
#254697   Looking at this example of a Term Sheet CallMeCrazy 01/23/19 08:19:56 PM
#254696   He has no financing... that's why i'm saying wsbc 01/23/19 07:36:58 PM
#254695   FINRA short sales of IPIX AlanC 01/23/19 07:36:56 PM
#254694   I agree,but not for his concern for other shareholders. kfcyahoo 01/23/19 07:17:56 PM
#254692   You don’t know ipix is a leo lifestyle scam? scottsmith 01/23/19 06:49:49 PM
#254691   Me either. TheDane 01/23/19 06:48:10 PM
#254690   Some already question that. Not me. Go IPIX! TheDane 01/23/19 06:47:48 PM
#254688   11 grand spent on IPIX stock today... Could Rdunn88 01/23/19 06:37:12 PM
#254687   Thanks for letting me know, I’ll take your snayeman 01/23/19 06:32:44 PM
#254686   B has become the latest failure... Leo loves Rdunn88 01/23/19 06:30:31 PM
#254685   You don’t know Leo is a crook? scottsmith 01/23/19 06:23:26 PM
#254684   RS would work if it was tied to Rdunn88 01/23/19 06:14:12 PM
#254683   I believe if he rs he knows it’s Mrvince 01/23/19 06:04:08 PM
#254682   Agree, we’re even more screwed if he did that! snayeman 01/23/19 06:01:22 PM
#254681   RS is a shell-game. wsbc 01/23/19 05:56:38 PM
#254680   I don't think Leo plans to give up Williamsc 01/23/19 05:56:32 PM
#254679  Restored Do you think he will reverse split IPIX? Blues44 01/23/19 05:50:27 PM
#254676   B hasn't made it to phase 3... It's Rdunn88 01/23/19 05:38:18 PM
#254675   If Leo cannot lock up a reasonable deal snayeman 01/23/19 05:04:40 PM
#254674   Amen! DaubersUP 01/23/19 04:22:08 PM
#254673   There are plenty of decisions that have been Lemoncat 01/23/19 03:44:16 PM
#254671   I don't think I will have to be zandant 01/23/19 03:35:21 PM
#254670   maybe a good 'ol fashion subpoena will wake MXAMDUD 01/23/19 03:25:35 PM
#254669   why? his horrid decisions got IPIX into MXAMDUD 01/23/19 02:47:03 PM
#254668   If he pulls a rabbit out of the zandant 01/23/19 02:38:36 PM
#254667   If that happens I'll eat my hat with leavetheguntakethecannolis 01/23/19 02:33:44 PM
#254666   I would not expect any apology as those AlanC 01/23/19 02:19:56 PM
#254665   a guy pulling down 500k year and costing MXAMDUD 01/23/19 02:17:48 PM
#254663   There are some pretty disgusting insinuations being thrown Lemoncat 01/23/19 01:59:16 PM
#254662   And that still remains THE BIG "IF". BooDog 01/23/19 01:34:42 PM
#254661   He is old and knows how to steal. Giovanni 01/23/19 12:46:46 PM
#254660   I'll be taking possession of all those fine MXAMDUD 01/23/19 12:43:12 PM
#254659   Like the mob, hopefully he gets indicted. MXAMDUD 01/23/19 12:42:24 PM
#254658   Who can afford to sue BK bizness? Giovanni 01/23/19 12:42:07 PM
#254657   "Definitely a sad state of affairs. All those Suvorov 01/23/19 11:47:21 AM
#254656   Exactly. But aside from the mob, zandant 01/23/19 11:24:36 AM
#254655   Financials? One-sided financials. The only thing to see zandant 01/23/19 11:23:32 AM
#254654   Third party validation is the key because after zandant 01/23/19 11:21:51 AM
#254653   Definitely a sad state of affairs. All zandant 01/23/19 11:19:53 AM
#254651   Leo has fumbled all those make believe deals. MXAMDUD 01/23/19 10:26:14 AM
#254650   That's what makes third party validation all the BooDog 01/23/19 10:25:32 AM
#254649   Profiting from biotech stocks on the otc has scottsmith 01/23/19 09:23:05 AM
#254648   Should see financials in the next couple weeks. BooDog 01/23/19 09:12:50 AM
PostSubject